about
Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activityTransthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to DiseaseThe role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysisManagement of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor.Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi-center data analysis using LiverMetSurvey.Identification and quantitative analysis of human transthyretin variants in human serum by Fourier transform ion-cyclotron resonance mass spectrometry.Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma.A non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MS.Two-stage strategy for patients with extensive bilateral colorectal liver metastases.α-Synuclein aggregation in the saliva of familial transthyretin amyloidosis: a potential biomarker.Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?Familial amyloid polyneuropathy and liver transplantation.The role of fibrinogen glycation in ATTR: evidence for chaperone activity loss in disease.Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignanciesOutcomes of parenchyma-preserving hepatectomy and right hepatectomy for solitary small colorectal liver metastasis: A LiverMetSurvey study.Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents.Long-term Results of Domino Liver Transplantation for Hepatocellular Carcinoma Using the "Double Piggy-back" Technique: A 13-Year Experience.Infections After Liver Transplantation: A Retrospective, Single-center Study.Is urinary γ-glutamyl transpeptidase superior to urinary neutrophil gelatinase-associated lipocalin for early prediction of acute kidney injury after liver transplantation?Effects of an exercise training program in physical condition after liver transplantation in familial amyloidotic polyneuropathy: a case report.Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients.Liver depurative techniques: a single liver transplantation center experience.Clinical outcomes and genetic expression profile in human liver graft dysfunction during ischemia/reperfusion injury.Prophylactic use of liposomal amphotericin B in preventing fungal infections early after liver transplantation: a retrospective, single-center study.Hepatic artery thrombosis in live liver donor transplantation: how to solve--a case report.Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cellsA nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients.Psychiatric and psychosocial predictors of medical outcome after liver transplantation: a prospective, single-center study.Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases.Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma.The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.Simultaneous Kidney-Pancreas Transplantation With an Original "Transverse Pancreas" Technique: Initial 9 Years' Experience With 56 Cases.Preoperative metabolic status is associated with different evolution of resting energy expenditure after liver transplant in adults.Ribavirin for Chronic Hepatitis E in Liver-Transplant Setting: A Safe and Highly Effective Therapy.Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding.Predictive variables affecting transfusion requirements in orthotopic liver transplantation.[Biliary Anastomosis in Liver Transplantation: With or Without T-Tube?]ABO-incompatible liver transplantation in acute liver failure: a single Portuguese center study.
P50
Q28477682-524B588D-F3AA-47A4-8791-230EEEA073F0Q28546193-1A5764E2-D64D-4469-A4BF-2DC6D35BC858Q30276213-B75B382D-EDEA-4858-917A-FE924555011FQ30360985-97CFD566-3ACF-47FD-8374-5C18347DC968Q30930073-A1DB50DF-A3C6-4ADE-8388-98427F7E123FQ33516156-3DA39B20-D76F-487E-B839-CFA084FC5945Q33554179-B8613F1B-37EC-4333-82A9-3D58EEAA4BD5Q33778879-1998C17A-E335-4DFD-A2F7-84DE89505A83Q33865026-E1DA9269-7798-438C-A679-74AFED4FDB32Q34271447-2A3687C9-149E-45D3-9A03-A6FC3F4487E6Q34336978-BB452862-9851-4566-917B-A5AFAA5154AAQ35755799-66355674-A406-410B-A060-A7E9D7B72657Q35853186-01BC3225-C9A0-4354-87D5-656A851DFE9FQ36025100-45FA1B36-5F15-4B2A-9A3B-568613D75DBEQ36120986-6A774893-6511-4C7C-BF31-FABA5D72AF20Q38824380-4D09DD97-FBA1-4ABE-B260-9B94752525B3Q38872876-D2295273-A39B-45D9-B58D-648B87260CA6Q38941197-9B206580-E1F1-473F-80DA-EA2F77AC10EDQ39000233-672FFA2B-5371-44EA-9442-EC81DCFD85FFQ39143992-7F3663EB-A8D5-4BA1-A1B4-6CAEB0DD0356Q39781035-95F5958E-821C-46A3-BF84-F87FDF347CA9Q40243471-1E6F0A4D-7D9A-48FF-9998-CAC394391221Q40876984-64E9C163-3304-4FA5-B297-6AA7B0757A0BQ40877050-9534002A-AC09-4935-9A66-98DBD55317B2Q41604307-AA7905BD-BDF8-4DD5-8FBF-60701F0DBBF7Q42199520-4E528BF5-0BDA-4165-A5D4-FA58D7EBC02BQ42275424-27E55F41-4868-4903-8E71-5154D991B01FQ43521512-9E0E2047-E512-4D8F-B4C2-20B351E7CA5FQ43977252-DC307E5E-C7C5-41F9-9EEB-C65E2B06C104Q44518903-1D74C489-B978-4B3B-8BC0-00ED9AC37300Q46008336-5FBB0845-A0FD-4205-91E0-90CAAB9A6189Q47173104-E91305AF-40A0-459C-A2AB-F501D84B97A8Q48024049-552A0788-D357-4EF5-B7CC-1507A0DD6F8DQ50037066-8E579428-F735-4A4D-BD2E-D9DC093E4795Q50051838-0654F171-6353-4911-BE81-C9F8151EFFB2Q50270995-031447E0-13E0-40D0-9662-A0B8B2B2D1B4Q50543352-AE1BADBA-4A83-490D-9C6F-E2E30399A6A5Q50570782-C1B71DE9-2947-4770-8DA8-4CBF9A4566A8Q50634155-EC2E83AE-1FDE-47F0-BC18-3679AB23D46FQ51037308-6FAE3B7F-D93A-4AB8-BFF9-F17D17F8E4F7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
E Barroso
@ast
E Barroso
@en
E Barroso
@es
E Barroso
@nl
E Barroso
@sl
type
label
E Barroso
@ast
E Barroso
@en
E Barroso
@es
E Barroso
@nl
E Barroso
@sl
prefLabel
E Barroso
@ast
E Barroso
@en
E Barroso
@es
E Barroso
@nl
E Barroso
@sl
P106
P1153
15029856000
P31
P496
0000-0001-9059-7362